Contamination of propofol infusions in the intensive care unit: incidence and clinical significance.
Epidemics of bacteraemia and wound infection have been associated with the infusion of bacterially contaminated propofol administered during anaesthesia. We conducted an observational study to determine the incidence and clinical significance of administration of potentially contaminated propofol to patients in an ICU setting. One hundred patients received a total of 302 infusions of propofol. Eighteen episodes of possible contamination of propofol syringes were identified, but in all cases contamination was by a low-grade virulence pathogen. There were no episodes of clinical infection or colonization which could be attributed to the administration of contaminated propofol. During the routine use of propofol to provide sedation in ICU patients the risk of nosocomial infection secondary to contamination of propofol is extremely low.
Webb
S A
SA
Department of Intensive Care, Sir Charles Gairdner Hospital, Perth, Western Australia.
Roberts
B
B
Breheny
F X
FX
Golledge
C L
CL
Cameron
P D
PD
van Heerden
P V
PV
D018806:APACHE; D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D004340:Drug Contamination; D005260:Female; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D019370:Observation; D015742:Propofol / Q000009:adverse effects*; D011446:Prospective Studies; D013530:Surgical Wound Infection / Q000453:epidemiology* / Q000382:microbiology*; D013594:Syringes / Q000382:microbiology*; D014904:Western Australia / Q000453:epidemiology
D018686:Anesthetics, Intravenous; D015742:Propofol